Ozempic
Ozempic (semaglutide) is a medication used to manage type 2 diabetes and support weight loss. It belongs to a class of drugs called GLP-1 receptor agonists, which help regulate blood sugar levels by increasing insulin production, reducing glucose production in the liver, and slowing down digestion. Ozempic is administered as a once-weekly injection and has been shown to lower blood sugar levels and promote weight loss in clinical trials.
| Detail | Information |
|---|---|
| Active Ingredient | Semaglutide |
| Brand Name | Ozempic |
| Drug Class | GLP-1 receptor agonist |
| Indications | Type 2 diabetes management, weight loss |
| Administration | Subcutaneous injection (once weekly) |
| Dosage Forms | 0.25 mg, 0.5 mg, 1 mg, 2 mg pre-filled pens |
| Common Side Effects | Nausea, vomiting, diarrhea, constipation, abdominal pain |
| Benefits | Lowers blood sugar levels, promotes weight loss, reduces risk of cardiovascular events |
| Contraindications | Personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2) |